Clinical Trial Update: Efficacy and Safety of Elagolix in Combination With Estradiol/Norethindrone Acetate for the Management of Heavy Menstrual Bleeding Associated With Uterine Fibroids in Premenopausal Women (Replicate Study) [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating elagolix with estradiol/norethindrone acetate for heavy menstrual bleeding due to uterine fibroids; results posted after completion in …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heavy Menstrual Bleeding
• Uterine Fibroids

Drugs mentioned

• ESTRADIOL / NORETHINDRONE ACETATE (Estradiol and norethindrone acetate)
• Elagolix (elagolix)

Snippet

Sponsor: AbbVie | Conditions: Uterine Fibroids, Heavy Menstrual Bleeding | Phase 3 | Status: COMPLETED | Results posted: 2020-06-30